[English] 日本語
Yorodumi- PDB-9osy: Tetrameric POLQ Helicase-like Domain Bound to Cmpd 36, a Small-Mo... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9osy | ||||||
|---|---|---|---|---|---|---|---|
| Title | Tetrameric POLQ Helicase-like Domain Bound to Cmpd 36, a Small-Molecule ATPase Inhibitor and Drug Candidate Analog | ||||||
Components | DNA polymerase theta | ||||||
Keywords | DNA BINDING PROTEIN / Theta-mediated end-joining DNA-dependent ATPase DNA repair Inhibitor co-complex | ||||||
| Function / homology | Function and homology informationdouble-strand break repair via alternative nonhomologous end joining / HDR through MMEJ (alt-NHEJ) / single-stranded DNA helicase activity / replication fork processing / mitochondrial nucleoid / site of DNA damage / 5'-deoxyribose-5-phosphate lyase activity / error-prone translesion synthesis / negative regulation of double-strand break repair via homologous recombination / somatic hypermutation of immunoglobulin genes ...double-strand break repair via alternative nonhomologous end joining / HDR through MMEJ (alt-NHEJ) / single-stranded DNA helicase activity / replication fork processing / mitochondrial nucleoid / site of DNA damage / 5'-deoxyribose-5-phosphate lyase activity / error-prone translesion synthesis / negative regulation of double-strand break repair via homologous recombination / somatic hypermutation of immunoglobulin genes / DNA helicase activity / base-excision repair / protein homooligomerization / RNA-directed DNA polymerase / RNA-directed DNA polymerase activity / double-strand break repair / site of double-strand break / DNA helicase / DNA-directed DNA polymerase / damaged DNA binding / DNA-directed DNA polymerase activity / DNA repair / DNA damage response / chromatin binding / magnesium ion binding / Golgi apparatus / ATP hydrolysis activity / nucleoplasm / ATP binding / identical protein binding / nucleus / cytosol Similarity search - Function | ||||||
| Biological species | Homo sapiens (human) | ||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.9 Å | ||||||
Authors | Zahn, K.E. / Mader, P. / Sicheri, F. | ||||||
| Funding support | 1items
| ||||||
Citation | Journal: J Med Chem / Year: 2025Title: The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor. Authors: Philippe Mochirian / Robert Papp / Marie-Claude Mathieu / Gino B Ferraro / Evelyne Dietrich / Bingcan Liu / David Bendahan / Alexander L Perryman / Simon Surprenant / Sara Fournier / Bita ...Authors: Philippe Mochirian / Robert Papp / Marie-Claude Mathieu / Gino B Ferraro / Evelyne Dietrich / Bingcan Liu / David Bendahan / Alexander L Perryman / Simon Surprenant / Sara Fournier / Bita Lotfollahzadeh Barzili / Alexanne Bonneau-Fortin / Shou Yun Yin / Marie-Eve Leclaire / Charmi Patel / Hugo Poirier / Sai Save / Yann Mathieu / Nicolas Morin / Claude Godbout / Helen E Burston / Karl E Zahn / Mohamed A Attia / Thomas Pinter / Francis Barabé / Paranjay Parikh / Chandresh Jagani / Gyunghoon Kang / Giovanna Scapin / Yael Mamane / Agnel Sfeir / Pavel Mader / Frank Sicheri / Michal Zimmermann / Anne Roulston / Stephen J Morris / W Cameron Black / Michel Gallant / ![]() Abstract: DNA polymerase theta (Polθ) plays a critical role in repairing DNA double-strand breaks through microhomology-mediated end joining (MMEJ) and has emerged as a key synthetic lethal drug target in ...DNA polymerase theta (Polθ) plays a critical role in repairing DNA double-strand breaks through microhomology-mediated end joining (MMEJ) and has emerged as a key synthetic lethal drug target in cancers with homologous recombination (HR) deficiencies. Its inhibition has shown a strong potential to synergize with PARP inhibitors, particularly in tumors with deleterious or mutations. Here, we describe the discovery and preclinical development of RP-2119, a selective, potent, and bioavailable Polθ ATPase inhibitor. Starting from a high-throughput ATPase screen combined with literature insights, key vectors for enhancing potency were identified by structural studies using single-particle cryo-electron microscopy (cryo-EM) that revealed the inhibitor binding site. Further optimization of potency and ADME properties led to the identification of RP-2119 with robust cellular activity in a wide range of HR-deficient cancer cell lines. In HR-deficient cell line- and patient-derived mouse xenografts, RP-2119 demonstrated strong synergy with the PARP inhibitor, olaparib, without exacerbating its hematological toxicity. | ||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9osy.cif.gz | 1007.7 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9osy.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 9osy.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 9osy_validation.pdf.gz | 1.7 MB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 9osy_full_validation.pdf.gz | 1.8 MB | Display | |
| Data in XML | 9osy_validation.xml.gz | 78.9 KB | Display | |
| Data in CIF | 9osy_validation.cif.gz | 118.1 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/os/9osy ftp://data.pdbj.org/pub/pdb/validation_reports/os/9osy | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 70813MC ![]() 9oswC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
| #1: Protein | Mass: 100884.812 Da / Num. of mol.: 4 / Fragment: N-terminal domain Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: POLQ, POLH / Production host: ![]() References: UniProt: O75417, DNA helicase, DNA-directed DNA polymerase, RNA-directed DNA polymerase #2: Chemical | ChemComp-A1CEQ / ( Mass: 550.576 Da / Num. of mol.: 4 / Source method: obtained synthetically / Formula: C28H24F2N4O4S / Feature type: SUBJECT OF INVESTIGATION Has ligand of interest | Y | Has protein modification | N | |
|---|
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Polymerase theta N-terminal domain in complex with ATPase inhibitor compound Type: COMPLEX / Entity ID: #1 / Source: RECOMBINANT |
|---|---|
| Molecular weight | Value: 0.4 MDa / Experimental value: NO |
| Source (natural) | Organism: Homo sapiens (human) |
| Source (recombinant) | Organism: ![]() |
| Buffer solution | pH: 7.5 Details: 20 mM HEPES pH 7.5, 300 mM NaCl, 1 mM TCEP, 5% glycerol |
| Specimen | Conc.: 1 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES Details: POLQ-ATPase + RP-12068 compound were mixed on ice in buffer to a final concentration of 1.00 mg/mL protein and 2x molar equivalents of the inhibitor compound |
| Vitrification | Cryogen name: ETHANE Details: 3 microL drop of sample suspension is applied to an EM grid that has been plasma-cleaned using a Gatan Solarus. After blotting the sample away with filter paper, grids are plunge-frozen in ...Details: 3 microL drop of sample suspension is applied to an EM grid that has been plasma-cleaned using a Gatan Solarus. After blotting the sample away with filter paper, grids are plunge-frozen in liquid ethane. Grids are stored under liquid nitrogen until transferred to the transmission electron microscope for imaging. |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM |
| Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 105000 X / Nominal defocus max: 1500 nm / Nominal defocus min: 1200 nm |
| Image recording | Electron dose: 53 e/Å2 / Film or detector model: GATAN K3 (6k x 4k) / Num. of real images: 5769 |
-
Processing
| EM software |
| |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | |||||||||||||||||||||||||
| Particle selection | Details: ~2.5M particles were initially selected from 4985 manually curated micrographs using cryoSPARC 3.1 live. All subsequent data processing was carried out in cryoSPARC 3.1.These particles were ...Details: ~2.5M particles were initially selected from 4985 manually curated micrographs using cryoSPARC 3.1 live. All subsequent data processing was carried out in cryoSPARC 3.1.These particles were subjected to 3 rounds of 2D classification. A subset of particles from the final round of 2D classification were used to train the Deep Learning particle picker Topaz (as implemented in cryoSPARC 3.1). The Topaz trained model was used to re-extract particles from the 4985 micrographs, yielding a new particle set comprising 387k particles. | |||||||||||||||||||||||||
| 3D reconstruction | Resolution: 2.9 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 387000 / Symmetry type: POINT | |||||||||||||||||||||||||
| Atomic model building | B value: 112.5 / Protocol: FLEXIBLE FIT / Space: REAL / Target criteria: CC_mask: 0.7952 | |||||||||||||||||||||||||
| Atomic model building | PDB-ID: 5AGA Accession code: 5AGA / Source name: PDB / Type: experimental model | |||||||||||||||||||||||||
| Refinement | Highest resolution: 2.9 Å Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | |||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
Citation




PDBj





FIELD EMISSION GUN
